Shujie Xia

3.7k total citations
122 papers, 2.8k citations indexed

About

Shujie Xia is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Urology. According to data from OpenAlex, Shujie Xia has authored 122 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 41 papers in Molecular Biology and 39 papers in Urology. Recurrent topics in Shujie Xia's work include Prostate Cancer Diagnosis and Treatment (31 papers), Urinary Bladder and Prostate Research (31 papers) and Prostate Cancer Treatment and Research (26 papers). Shujie Xia is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (31 papers), Urinary Bladder and Prostate Research (31 papers) and Prostate Cancer Treatment and Research (26 papers). Shujie Xia collaborates with scholars based in China, United States and Taiwan. Shujie Xia's co-authors include Bangmin Han, Di Cui, Yifeng Jing, Chenyi Jiang, Qi Jiang, Xiaohai Wang, Fujun Zhao, Yinong Niu, Yuan Ruan and Yiping Zhu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Shujie Xia

118 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shujie Xia China	33	1.1k	970	689	640	523	122	2.8k
Yun‐Sok Ha South Korea	26	1.2k 1.1×	1.0k 1.0×	522 0.8×	271 0.4×	979 1.9×	194	2.8k
Joseph Wagner United States	29	1.0k 0.9×	724 0.7×	679 1.0×	404 0.6×	715 1.4×	112	2.8k
Hiromitsu Mimata Japan	27	1.1k 1.0×	647 0.7×	632 0.9×	250 0.4×	522 1.0×	181	2.9k
Akio Horiguchi Japan	28	940 0.8×	684 0.7×	617 0.9×	295 0.5×	546 1.0×	161	2.4k
Mikio Igawa Japan	40	2.2k 2.0×	1.1k 1.2×	520 0.8×	422 0.7×	1.1k 2.1×	175	4.1k
Bangmin Han China	24	582 0.5×	652 0.7×	334 0.5×	479 0.7×	257 0.5×	81	1.7k
Kun Tang China	33	1.5k 1.4×	918 0.9×	1.1k 1.6×	206 0.3×	459 0.9×	129	3.0k
Yinglu Guo China	27	1.1k 1.0×	368 0.4×	419 0.6×	257 0.4×	210 0.4×	75	2.2k
Dong‐Myung Shin South Korea	32	1.2k 1.1×	569 0.6×	199 0.3×	404 0.6×	604 1.2×	111	2.8k
Xunbo Jin China	28	791 0.7×	317 0.3×	441 0.6×	272 0.4×	427 0.8×	83	1.8k

Countries citing papers authored by Shujie Xia

Since Specialization

Citations

This map shows the geographic impact of Shujie Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujie Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujie Xia more than expected).

Fields of papers citing papers by Shujie Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujie Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujie Xia. The network helps show where Shujie Xia may publish in the future.

Co-authorship network of co-authors of Shujie Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Shujie Xia. A scholar is included among the top collaborators of Shujie Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujie Xia. Shujie Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jiahao, et al.. (2025). Extracellular Matrix Stiffness Enhancement Promotes Docetaxel Resistance in Prostate Cancer via Inhibition of Apoptosis Mediated by Upregulation of PRRX1. International Journal of Medical Sciences. 22(13). 3454–3463.

Ma, Yiqun, Shujie Xia, Annan Hu, et al.. (2025). Ultrabright contrast agents with synergistic Raman enhancements for precise intraoperative imaging and photothermal ablation of orthotopic tumor models. Journal of Nanobiotechnology. 23(1). 26–26. 5 indexed citations

Han, Bangmin, et al.. (2024). Beyond size: A comprehensive overview of small-volume benign prostatic hyperplasia. Current Urology. 19(1). 1–5.

Deng, Zheng, et al.. (2023). Activation of the HNRNPA2B1/miR-93-5p/FRMD6 axis facilitates prostate cancer progression in an m6A-dependent manner. Journal of Cancer. 14(7). 1242–1256. 17 indexed citations

Cao, Tianyu, Feng Xie, Yi Liu, et al.. (2023). Rapamycin and Low-dose IL-2 Mediate an Immunosuppressive Microenvironment to Inhibit Benign Prostatic Hyperplasia. International Journal of Biological Sciences. 19(11). 3441–3455. 2 indexed citations

Tang, Xiaohu, Hao Liu, Heng Zhang, et al.. (2023). Construction of lncRNA- and circRNA-associated ceRNA networks in the prostatic urethra of rats after simulating transurethral laser prostatectomy (TULP). Molecular and Cellular Biochemistry. 479(6). 1363–1377. 1 indexed citations

Ni, Xiaoqing, et al.. (2022). ROS–NLRP3 signaling pathway induces sterile inflammation after thulium laser resection of the prostate. Journal of Cellular Physiology. 237(3). 1923–1935. 8 indexed citations

Yan, Yi‐Lin, et al.. (2022). Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer. Frontiers in Molecular Biosciences. 9. 815290–815290. 5 indexed citations

Fan, Guangjian, Lianhui Sun, Ling Meng, et al.. (2021). The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation. Nature Communications. 12(1). 20–20. 50 indexed citations

10.

Zhao, Sheng, Di Cui, Yu Zhang, et al.. (2017). Androgen receptor antagonist bicalutamide induces autophagy and apoptosis via ULK2 upregulation in human bladder cancer cells.. PubMed Central. 10(7). 7603–7615. 4 indexed citations

11.

Tao, Le, Jianxin Qiu, Ming Jiang, et al.. (2016). Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals. Molecular Cancer Therapeutics. 15(8). 1943–1951. 18 indexed citations

12.

Jiang, Juntao, Zhong Chen, Yiping Zhu, et al.. (2016). Prenatal exposure to di-n-butyl phthalate (DBP) differentially alters androgen cascade in undeformed versus hypospadiac male rat offspring. Reproductive Toxicology. 61. 75–81. 25 indexed citations

13.

Cui, Di, Jinlu Dai, Jill M. Keller, et al.. (2015). Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer. Clinical Cancer Research. 21(20). 4619–4629. 80 indexed citations

14.

Kyriazis, Iason, Mathias Wolters, Christopher Netsch, et al.. (2015). Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement. World Journal of Urology. 33(4). 525–530. 55 indexed citations

15.

Wang, Xiaohai, Soo Ok Lee, Shujie Xia, et al.. (2013). Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6→Androgen Receptor→TGF-β→MMP-9 Signals. Molecular Cancer Therapeutics. 12(6). 1026–1037. 82 indexed citations

16.

Wu, Jitao, Bangmin Han, Shengqiang Yu, Huiping Wang, & Shujie Xia. (2010). Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer. Urology. 75(4). 820–827. 69 indexed citations

17.

Xia, Shujie. (2009). Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian Journal of Andrology. 11(3). 277–281. 52 indexed citations

18.

Yu, Shengqiang, Bangmin Han, Yi Shao, et al.. (2009). Androgen receptor functioned as a suppressor in the prostate cancer cell line PC3 in vitro and in vivo. Chinese Medical Journal. 122(22). 2779–2783. 5 indexed citations

19.

Li, Runsheng, Yan Guo, Xiaowei Yan, et al.. (2008). Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidates. PROTEOMICS - CLINICAL APPLICATIONS. 2(4). 543–555. 20 indexed citations

20.

Liu, Jianhe, Ming Li, & Shujie Xia. (2004). [Expression and clinical significance of antiapoptosis gene XIAP in prostate cancer].. PubMed. 10(11). 832–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact